HK1191645A1 - -甲氧基-吡啶- -基衍生物 - Google Patents

-甲氧基-吡啶- -基衍生物

Info

Publication number: HK1191645A1
Authority: HK; Hong Kong
Prior art keywords: pyridine; methoxy; based derivatives; derivatives
Prior art date: 2011-01-19

Application number

HK14104850.5A

Other languages

English (en)

Inventor

Martin Bolli

Cyrille Lescop

Boris Mathys

Keith Morrison

Claus Mueller

Oliver Nayler

Beat Steiner

Original Assignee

Actelion Pharmaceuticals Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-01-19

Filing date

2014-05-23

Publication date

2014-08-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45607310&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1191645(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2014-05-23 Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd

2014-08-01 Publication of HK1191645A1 publication Critical patent/HK1191645A1/zh

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Ophthalmology & Optometry (AREA)
Biomedical Technology (AREA)
Oncology (AREA)
Neurosurgery (AREA)
Hematology (AREA)
Physical Education & Sports Medicine (AREA)
Emergency Medicine (AREA)
Urology & Nephrology (AREA)
Transplantation (AREA)
Otolaryngology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyridine Compounds (AREA)

HK14104850.5A 2011-01-19 2014-05-23 -甲氧基-吡啶- -基衍生物 HK1191645A1 (zh)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IB2011050241		2011-01-19
PCT/IB2012/050241 WO2012098505A1 (en)	2011-01-19	2012-01-18	2-methoxy-pyridin-4-yl derivatives

Publications (1)

Publication Number	Publication Date
HK1191645A1 true HK1191645A1 (zh)	2014-08-01

Family

ID=45607310

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK14104850.5A HK1191645A1 (zh)	2011-01-19	2014-05-23	-甲氧基-吡啶- -基衍生物

Country Status (29)

Country	Link
US (1)	US9133179B2 (zh)
EP (1)	EP2665720B1 (zh)
JP (1)	JP5859570B2 (zh)
KR (1)	KR101869120B1 (zh)
CN (1)	CN103313981B (zh)
AR (1)	AR084883A1 (zh)
AU (1)	AU2012208325B2 (zh)
BR (1)	BR112013017923B1 (zh)
CA (1)	CA2818470C (zh)
CL (1)	CL2013002056A1 (zh)
CY (1)	CY1116657T1 (zh)
DK (1)	DK2665720T3 (zh)
ES (1)	ES2544086T3 (zh)
HK (1)	HK1191645A1 (zh)
HR (1)	HRP20150919T1 (zh)
HU (1)	HUE026012T2 (zh)
IL (1)	IL227509A0 (zh)
MA (1)	MA34910B1 (zh)
MX (1)	MX350009B (zh)
MY (1)	MY163185A (zh)
PH (1)	PH12013501487A1 (zh)
PL (1)	PL2665720T3 (zh)
PT (1)	PT2665720E (zh)
SG (1)	SG191742A1 (zh)
SI (1)	SI2665720T1 (zh)
TW (1)	TWI546300B (zh)
UA (1)	UA109804C2 (zh)
WO (1)	WO2012098505A1 (zh)
ZA (1)	ZA201306193B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2014229217B2 (en)	2013-03-15	2017-12-14	Idorsia Pharmaceuticals Ltd	Pyridin-4-yl derivatives
US9629834B2 (en)	2013-04-26	2017-04-25	Kyoto University	Medicinal composition for inhibiting formation and/or enlargement of cerebral aneurysm or shrinking same
CN105760707B (zh) *	2014-12-18	2018-07-31	中国科学院大连化学物理研究所	细胞基因翻译过程建模方法
KR102220848B1 (ko) *	2015-05-20	2021-02-26	이도르시아 파마슈티컬스 리미티드	화합물 (s)-3-｛4-[5-(2-시클로펜틸-6-메톡시-피리딘-4-일)-[1,2,4]옥사디아졸-3-일]-2-에틸-6-메틸-페녹시｝-프로판-1,2-디올의 결정형
CN107382965A (zh) *	2017-08-14	2017-11-24	河南科技大学第附属医院	具有抗肿瘤活性的新型s1p‑1受体激动剂药物分子的合成方法

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3647809A (en)	1968-04-26	1972-03-07	Chinoin Gyogyszer Es Vegyeszet	Certain pyridyl-1 2 4-oxadiazole derivatives
AU7686891A (en)	1990-04-05	1991-10-30	American National Red Cross, The	A protein family related to immediate-early protein expressed by human endothelial cells during differentiation
CA2051494C (en)	1990-09-20	2006-03-14	Robert J. Dinerstein	1-aryl-3-pyridinyl-2-propene-1-ones as calcium uptake inhibitors
DE4429465A1 (de)	1994-08-19	1996-02-22	Bayer Ag	Verfahren zur Herstellung von 2-Halogenpyridinaldehyden und neue 2-Halogenpyridinaldehyde
US6423508B1 (en)	1998-03-09	2002-07-23	Smithkline Beecham Corporation	Polynucleotide sequences of human EDG-1c
DE19904389A1 (de)	1999-02-04	2000-08-10	Bayer Ag	Verwendung von substituierten Isoxazolcarbonsäuren und Derivate und neue Stoffe
BR0013427A (pt)	1999-08-19	2002-07-30	Nps Pharma Inc	Compostos heteropolicìclicos e seus usos como antagonistas no receptor de glutamato metabotrópico
KR100838447B1 (ko)	2001-02-21	2008-06-16	아스트라제네카 아베	헤테로폴리시클릭 화합물 및 대사향성 글루타메이트수용체 길항제로서의 그의 용도
WO2003062252A1 (en)	2002-01-18	2003-07-31	Merck & Co., Inc.	Edg receptor agonists
JP4709488B2 (ja)	2002-01-18	2011-06-22	メルク・シャープ・エンド・ドーム・コーポレイション	Ｅｄｇ受容体作動薬としてのＮ−（ベンジル）アミノアルキルカルボン酸化合物、ホスフィン酸化合物、ホスホン酸化合物およびテトラゾール類
AU2003276043A1 (en)	2002-06-17	2003-12-31	Merck & Co., Inc.	1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists
DE10237883A1 (de)	2002-08-19	2004-03-04	Merckle Gmbh Chem.-Pharm. Fabrik	Substituierte Isoxazolderivate und ihre Verwendung in der Pharmazie
WO2004035538A1 (en)	2002-10-15	2004-04-29	Merck & Co., Inc.	Process for making azetidine-3-carboxylic acid
US20050004186A1 (en)	2002-12-20	2005-01-06	Pfizer Inc	MEK inhibiting compounds
EP1625123A4 (en)	2003-05-15	2007-08-29	Merck & Co Inc	3- (2-AMINO-1-AZACYCLYL) -5-ARYL-1,2,4-OXADIAZOLE AS S1P RECEPTOR AGONISTS
TW200505416A (en)	2003-08-12	2005-02-16	Mitsubishi Pharma Corp	Bi-aryl compound having immunosuppressive activity
EP1670463A2 (en)	2003-10-01	2006-06-21	Merck & Co., Inc.	3,5-aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as s1p receptor agonists
CA2547198A1 (en)	2003-12-17	2005-06-30	Merck & Co., Inc.	(3,4-disubstituted)propanoic carboxylates as s1p (edg) receptor agonists
EA014729B1 (ru)	2004-05-29	2011-02-28	7ТиЭм ФАРМА А/С	Лиганды crth2 рецептора и их применение
WO2006010379A1 (en)	2004-07-29	2006-02-02	Actelion Pharmaceuticals Ltd.	Novel thiophene derivatives as immunosuppressive agents
AU2005299851B2 (en)	2004-10-22	2011-03-17	Merck Sharp & Dohme Corp.	2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as S1P receptor agonists
PT1826197E (pt)	2004-12-13	2012-03-06	Ono Pharmaceutical Co	Derivado de ácido aminocarboxílico e sua utilização medicinal
CN101180050B (zh)	2005-03-23	2011-07-27	埃科特莱茵药品有限公司	作为鞘氨醇-1-磷酸盐-1受体激动剂的新颖噻吩衍生物
ES2365747T3 (es)	2005-03-23	2011-10-10	Actelion Pharmaceuticals Ltd.	Derivados de benzo[c]tiofeno hidrogenados como inmunomoduladores.
PL1863474T3 (pl)	2005-03-23	2009-04-30	Actelion Pharmaceuticals Ltd	Nowe pochodne tiofenu jako agoniści receptora 1 1-fosforanu sfingozyny
AU2006232105A1 (en)	2005-04-05	2006-10-12	Pharmacopeia, Inc.	Purine and imidazopyridine derivatives for immunosuppression
JPWO2006115188A1 (ja)	2005-04-22	2008-12-18	第一三共株式会社	ヘテロ環化合物
ATE477253T1 (de)	2005-04-26	2010-08-15	Neurosearch As	Neuartige oxadiazol-derivate und deren medizinische verwendung
AU2006256968A1 (en)	2005-06-08	2006-12-14	Novartis Ag	Polycyclic oxadiazoles or I soxazoles and their use as SIP receptor ligands
US20070043104A1 (en)	2005-06-10	2007-02-22	Luthman Ingrid K	UII-modulating compounds and their use
RU2008101805A (ru)	2005-06-24	2009-07-27	Актелион Фармасьютиклз Лтд (Ch)	Новые производные тиофена
JP2008546836A (ja)	2005-06-28	2008-12-25	アストラゼネカアクチボラグ	新規な用途
AR057894A1 (es)	2005-11-23	2007-12-26	Actelion Pharmaceuticals Ltd	Derivados de tiofeno
TWI404706B (zh) *	2006-01-11	2013-08-11	Actelion Pharmaceuticals Ltd	新穎噻吩衍生物
PL1979345T3 (pl)	2006-01-24	2010-04-30	Actelion Pharmaceuticals Ltd	Nowe pochodne pirydyny
GB0601744D0 (en)	2006-01-27	2006-03-08	Novartis Ag	Organic compounds
WO2007098474A1 (en)	2006-02-21	2007-08-30	University Of Virginia Patent Foundation	Phenyl-cycloalkyl and phenyl-heterocyclic derivatives as s1p receptor agonists
JP4383525B2 (ja)	2006-05-09	2009-12-16	ファイザー・プロダクツ・インク	シクロアルキルアミノ酸誘導体およびその医薬組成物
TWI408139B (zh)	2006-09-07	2013-09-11	Actelion Pharmaceuticals Ltd	新穎噻吩衍生物
PL2069336T3 (pl) *	2006-09-07	2013-05-31	Idorsia Pharmaceuticals Ltd	Pochodne pirydyn-4-ylu jako środki immunomodulujące
EP2069335B1 (en)	2006-09-08	2012-12-26	Actelion Pharmaceuticals Ltd.	Pyridin-3-yl derivatives as immunomodulating agents
WO2008035239A1 (en)	2006-09-21	2008-03-27	Actelion Pharmaceuticals Ltd	Phenyl derivatives and their use as immunomodulators
KR20090057070A (ko)	2006-09-29	2009-06-03	노파르티스 아게	소염성 및 면역억제성을 갖는 옥사디아졸 유도체
JP2008120794A (ja)	2006-10-16	2008-05-29	Daiichi Sankyo Co Ltd	ヘテロ環化合物を含有する医薬組成物
BRPI0720043A2 (pt)	2006-12-15	2014-01-07	Abbott Lab	Composto oxadiazol
US20110207704A1 (en)	2006-12-15	2011-08-25	Abbott Laboratories	Novel Oxadiazole Compounds
WO2008091967A1 (en)	2007-01-26	2008-07-31	Smithkline Beecham Corporation	Chemical compounds
ES2450750T3 (es) *	2007-03-16	2014-03-25	Actelion Pharmaceuticals Ltd.	Derivados de amino-piridina como agonistas del receptor S1P1/EDG1
JP5451614B2 (ja)	2007-08-17	2014-03-26	アクテリオンファーマシューティカルズリミテッド	Ｓ１ｐ１／ｅｄｇ１受容体調節剤としてのピリジン誘導体
EP2193125B1 (en)	2007-10-04	2017-01-11	Merck Serono S.A.	Oxadiazole derivatives
CA2696829C (en)	2007-10-04	2017-07-04	Merck Serono S.A.	Oxadiazole diaryl compounds
CN101970430B (zh)	2007-11-01	2013-05-08	埃科特莱茵药品有限公司	嘧啶衍生物
JP2011503046A (ja)	2007-11-08	2011-01-27	ファイザー・インク	シクロブチルカルボン酸誘導体
US8148410B2 (en)	2007-12-10	2012-04-03	Actelion Pharmaceuticals Ltd.	Thiophene derivatives as agonists of S1P1/EDG1
WO2009078983A1 (en) *	2007-12-18	2009-06-25	Arena Pharmaceuticals, Inc.	Tetrahydrocyclopenta[b]indol-3-yl carboxylic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
JP2011513385A (ja)	2008-03-06	2011-04-28	アクテリオンファーマシューティカルズリミテッド	新規なピリミジン−ピリジン誘導体
ES2389042T3 (es)	2008-03-06	2012-10-22	Actelion Pharmaceuticals Ltd.	Compuestos de piridina
MY183039A (en)	2008-03-07	2021-02-08	Idorsia Pharmaceuticals Ltd	Pyridin-2-yl derivatives as immunomodulating agents
WO2009109904A1 (en)	2008-03-07	2009-09-11	Actelion Pharmaceuticals Ltd	Novel aminomethyl benzene derivatives
ES2813368T3 (es)	2008-05-14	2021-03-23	Scripps Research Inst	Nuevos moduladores de receptores de fosfato de esfingosina
TW201107302A (en)	2009-06-26	2011-03-01	Glaxo Group Ltd	Compounds
WO2011007324A1 (en) *	2009-07-16	2011-01-20	Actelion Pharmaceuticals Ltd	Pyridin-4-yl derivatives

2012
- 2012-01-18 PH PH1/2013/501487A patent/PH12013501487A1/en unknown
- 2012-01-18 MX MX2013007726A patent/MX350009B/es active IP Right Grant
- 2012-01-18 TW TW101101997A patent/TWI546300B/zh active
- 2012-01-18 HU HUE12704125A patent/HUE026012T2/en unknown
- 2012-01-18 UA UAA201309611A patent/UA109804C2/ru unknown
- 2012-01-18 BR BR112013017923-6A patent/BR112013017923B1/pt not_active IP Right Cessation
- 2012-01-18 ES ES12704125.9T patent/ES2544086T3/es active Active
- 2012-01-18 DK DK12704125.9T patent/DK2665720T3/en active
- 2012-01-18 SG SG2013047212A patent/SG191742A1/en unknown
- 2012-01-18 EP EP12704125.9A patent/EP2665720B1/en active Active
- 2012-01-18 MA MA36184A patent/MA34910B1/fr unknown
- 2012-01-18 CN CN201280005493.7A patent/CN103313981B/zh not_active Expired - Fee Related
- 2012-01-18 KR KR1020137020321A patent/KR101869120B1/ko not_active Expired - Fee Related
- 2012-01-18 PL PL12704125T patent/PL2665720T3/pl unknown
- 2012-01-18 AR ARP120100163A patent/AR084883A1/es unknown
- 2012-01-18 AU AU2012208325A patent/AU2012208325B2/en not_active Ceased
- 2012-01-18 MY MYPI2013701260A patent/MY163185A/en unknown
- 2012-01-18 CA CA2818470A patent/CA2818470C/en active Active
- 2012-01-18 JP JP2013549917A patent/JP5859570B2/ja not_active Expired - Fee Related
- 2012-01-18 WO PCT/IB2012/050241 patent/WO2012098505A1/en active Application Filing
- 2012-01-18 SI SI201230254T patent/SI2665720T1/sl unknown
- 2012-01-18 PT PT127041259T patent/PT2665720E/pt unknown
- 2012-01-18 US US13/980,764 patent/US9133179B2/en active Active
2013
- 2013-07-17 IL IL227509A patent/IL227509A0/en active IP Right Grant
- 2013-07-17 CL CL2013002056A patent/CL2013002056A1/es unknown
- 2013-08-16 ZA ZA2013/06193A patent/ZA201306193B/en unknown
2014
- 2014-05-23 HK HK14104850.5A patent/HK1191645A1/zh not_active IP Right Cessation
2015
- 2015-08-28 CY CY20151100762T patent/CY1116657T1/el unknown
- 2015-09-02 HR HRP20150919TT patent/HRP20150919T1/hr unknown

Also Published As

Publication number	Publication date
ZA201306193B (en)	2016-07-27
RU2013138285A (ru)	2015-02-27
BR112013017923A2 (pt)	2017-03-21
AR084883A1 (es)	2013-07-10
MY163185A (en)	2017-08-15
WO2012098505A1 (en)	2012-07-26
CA2818470A1 (en)	2012-07-26
SG191742A1 (en)	2013-08-30
IL227509A0 (en)	2013-09-30
HRP20150919T1 (hr)	2015-09-25
MA34910B1 (fr)	2014-02-01
MX2013007726A (es)	2013-08-09
PH12013501487A1 (en)	2019-10-11
KR20140014128A (ko)	2014-02-05
UA109804C2 (xx)	2015-10-12
CL2013002056A1 (es)	2013-12-27
US9133179B2 (en)	2015-09-15
CN103313981B (zh)	2016-05-11
TW201309681A (zh)	2013-03-01
AU2012208325B2 (en)	2016-12-22
BR112013017923A8 (pt)	2017-12-26
US20130303514A1 (en)	2013-11-14
AU2012208325A1 (en)	2013-09-05
CN103313981A (zh)	2013-09-18
JP2014502994A (ja)	2014-02-06
EP2665720B1 (en)	2015-06-10
PL2665720T3 (pl)	2015-11-30
MX350009B (es)	2017-08-23
EP2665720A1 (en)	2013-11-27
PT2665720E (pt)	2015-09-16
CA2818470C (en)	2019-03-05
ES2544086T3 (es)	2015-08-27
BR112013017923B1 (pt)	2021-08-10
HUE026012T2 (en)	2016-05-30
KR101869120B1 (ko)	2018-06-19
SI2665720T1 (sl)	2015-08-31
DK2665720T3 (en)	2015-07-13
JP5859570B2 (ja)	2016-02-10
CY1116657T1 (el)	2018-04-04
NZ614367A (en)	2015-02-27
TWI546300B (zh)	2016-08-21

Publication	Publication Date	Title
CO6890099A2 (es)	2014-03-10	Nuevos derivados dihidroquinolina-2-ona
DK2744810T4 (da)	2023-11-20	Tenofovir-alafenamid-hemifumarat
EP2780065A4 (en)	2015-05-27	NASAL MASK SYSTEM
EP2768410A4 (en)	2015-09-02	EXTENSION COLLAR SYSTEM
EP2664141A4 (en)	2013-12-11	UNBLOCKING FILTERING
DK2769050T3 (da)	2021-05-17	Propsensor
EP2748335A4 (en)	2015-05-06	BIOLOGICAL MARKERS OF URINE
BR112014000879A2 (pt)	2017-02-21	deflegmador
DE102011100082A8 (de)	2013-01-10	Traygreifvorrichtung
DK3272861T3 (da)	2020-03-23	Alpha-galactosidase-sammensætninger
EP2795884A4 (en)	2015-07-29	Audio conferencing
CO6960543A2 (es)	2014-05-30	2-tiopirimidinonas
EP2786752A4 (en)	2015-05-06	Ropinirole-containing adhesive patch
EP2768739A4 (en)	2015-10-21	EYEWASH FLUID CONTAINER
DK3141251T3 (da)	2021-02-01	Koloskopi - forberedelse
CO6960557A2 (es)	2014-05-30	Derivados de 2-yodo-imidazol
EP2738148A4 (en)	2015-05-27	RECIPROCAL LOCKING BLOCK
DE112011104936A5 (de)	2013-11-28	Stanzstauchniet
PL2762466T3 (pl)	2017-09-29	Pochodna fenylu
EP2760803A4 (en)	2015-07-08	Geopolymer product
HK1191645A1 (zh)	2014-08-01	-甲氧基-吡啶- -基衍生物
EP2788163A4 (en)	2015-10-21	POST-MOLDING SYSTEM
EP2729467A4 (en)	2014-05-14	CRYPTATE COMPOUNDS
EP2698098A4 (en)	2014-10-29	campimeter
DE112012000958A5 (de)	2013-11-28	Handsäge

Legal Events

Date	Code	Title	Description
2020-09-04	PC	Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)	Effective date: 20200121